BIIB Earnings: Biogen Q1 2025 adj. profit drops despite higher revenues
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Thursday reported a year-over-year decrease in adjusted profit for the first quarter of 2025, despite an increase in revenues. Total revenue rose 6% year-over-year to $2.4 billion in the March quarter. For the full year of 2025, the company expects revenues to decline by a mid-single-digit percentage annually, at … Read more